Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.

BACKGROUND: Hematopoietic stem cell transplantation is a curative treatment for several haematological malignancies. However, treatment related morbidity and mortality still is a limiting factor. Cyclophosphamide is widely used in condition regimens either in combination with other chemotherapy or w...

Full description

Bibliographic Details
Main Authors: Ibrahim El-Serafi, Manuchehr Abedi-Valugerdi, Zuzana Potácová, Parvaneh Afsharian, Jonas Mattsson, Ali Moshfegh, Moustapha Hassan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3899295?pdf=render